Senomyx collaborates with PepsiCo to identify salt flavors with modifying properties

NewsGuard 100/100 Score

Senomyx, Inc. (NASDAQ: SNMX), a leading company in using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor industries, announced today that it has entered into a new collaborative agreement with PepsiCo, Inc. related to Senomyx's Salt Taste Program. The new collaboration will support Senomyx's continued work to identify flavors with modifying properties intended to restore the desired salty taste in products with reduced salt (sodium chloride). 

Under the new agreement, PepsiCo will provide research funding for the Salt Taste Program for 2014 and has options to extend the research funding period.  PepsiCo will have non-exclusive rights to salt flavor modifiers discovered during the research funding period. In addition, Senomyx will have the right to supply these flavor ingredients directly to PepsiCo.  Financial terms of the agreement have not been disclosed.

"We are pleased to establish this new type of research agreement, which provides research funding to Senomyx while retaining our ability to add potential new flavor offerings to our direct sales portfolio," said John Poyhonen, President and Chief Executive Officer of the Company.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses